The accused killer of Brian Thompson cited the industry’s failures as his motive for assassinating the UnitedHealth executive ...

The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...

"While this information is theoretically available to the public, institutional owners' holdings are challenging to identify ...

An Alabama lawmaker believes prescription care management should be a legislative priority during the upcoming session.

A new report from the Federal Trade Commission is uncovering what appears to be a major driver of the high cost of ...

As the use of generative AI continues to expand, 2025 is poised to be the year this technology significantly starts to change how Americans live and work. This is especially true in the P&C industry, ...

Needham analyst Matthew Shea has reiterated their bullish stance on EVH stock, giving a Buy rating yesterday.Stay Ahead of the Market:Discover ...

Mattingly is an associate professor and vice chair of research in the Department of Pharmacotherapy at the University of Utah ...

The U.S. Federal Trade Commission on Tuesday published the second part of its investigation into how prescription drug ...

The three largest pharmacy benefit managers (PBMs) inflated the price of specialty generic drugs beyond their costs of ...

In today’s dynamic, customizable wellness landscape, brands have a unique opportunity to stay ahead of the curve.